News
DGAP-Adhoc: Carl Zeiss Meditec achieves EBIT margin of 18.1% in fiscal year 2018/19
DGAP-Adhoc: Carl Zeiss Meditec erzielt EBIT-Marge von 18,1% im Geschäftsjahr 2018/19
DGAP-News: Doctolib und ifa systems AG vereinbaren Kooperation
EQS-Adhoc: AEVIS VICTORIA SA: Integration der Seiler Hotels in Zermatt
EQS-Adhoc: AEVIS VICTORIA SA: Integration of Seiler Hotels in Zermatt
DGAP-Adhoc: Drägerwerk AG & Co. KGaA: Vorläufige Geschäftszahlen für das 3. Quartal. Umsatzprognose wird angehoben.
DGAP-Adhoc: Drägerwerk AG & Co. KGaA: preliminary result for the third quarter. Increased guidance for net sales development.
DGAP-News: Veränderung im Aufsichtsrat der MEDICLIN
DGAP-News: Change in the Supervisory Board of MEDICLIN
DGAP-News: Gerresheimer AG: Gerresheimer treibt Wachstums- und Technologieprojekte im dritten Quartal voran
DGAP-News: Gerresheimer AG: Gerresheimer advances growth and technology projects in third quarter
DGAP-News: Biom'up announces the approval of HEMOBLAST(TM) Bellows and its laparoscopic applicator in Australia
2 Beaten-Down Growth Stocks You Might Regret Not Buying
Stock market crashes look daunting on a chart so long as we restrict ourselves to a short time horizon. But the more we zoom out, the more they look like minor blips as equities always recover and
Is DexCom a Millionaire Maker?
Diabetes is a global epidemic, with more than 537 million people affected worldwide. DexCom (NASDAQ: DXCM) has improved patient lives with technology, and the stock has outperformed the stock market
Want $1 Million in Retirement? 3 Stocks to Buy Now and Hold for Decades
Do you want to retire a millionaire? Unless you're one of the lucky few who can build a successful business or who's born with rich relatives, your best path toward that goal is likely to involve
Why AngioDynamics Stock Is Crashing Today
Shares of AngioDynamics (NASDAQ: ANGO) were crashing 17.1% lower as of 10:43 a.m. ET on Thursday. The steep sell-off came after the medical technology company announced its fiscal 2025 first-quarter
Down More Than 50%, Is DexCom Stock a Bargain Now?
This year started with healthy gains for DexCom (NASDAQ: DXCM) stock, but they didn't last long. The medical device stock is now down by about 53% from the high-water mark it set in April.
DexCom
Humana’s 2025 Medicare Advantage Plans Focus on Quality, Affordable Healthcare Tailored to the Needs of Consumers
Leading health and well-being company Humana Inc. (NYSE: HUM) today announced its Medicare Advantage and Medicare Prescription Drug Plan offerings for 2025.
This press release features multimedia
EQS-News: Drägerwerk AG & Co. KGaA: Notification pursuant to Art. 5 (1) of the Regulation (EU) No 596/2014 and Art. 2 (1) of the Delegated Regulation (EU) 2016/1052 of the Commission
EQS-Adhoc: Gerresheimer AG: Adjustment of growth guidance for 2024 and 2025
2 Magnificent Growth Stocks Down 45% and 32% to Buy Right Now
The market has discounted a fair number of stocks over the last few years, and some for good reason. At the same time, share price alone tells you relatively little other than what the broader